Ana Belchior, Bianca C Alves, Edgar Mendes, Francisco Megre, Luís C Alves, Pedro Santos, Kai Nishimura, Hiroyuki Nakamura, Francesc Teixidor, Clara Viñas, Jorge Miguel Sampaio, Fernanda Marques, Teresa Pinheiro
{"title":"揭示质子硼与阴离子金属碳硼烷([o-COSAN]-)在乳腺癌细胞中的融合反应的物理和放射生物学效应。","authors":"Ana Belchior, Bianca C Alves, Edgar Mendes, Francisco Megre, Luís C Alves, Pedro Santos, Kai Nishimura, Hiroyuki Nakamura, Francesc Teixidor, Clara Viñas, Jorge Miguel Sampaio, Fernanda Marques, Teresa Pinheiro","doi":"10.1186/s13550-025-01199-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Protons, which are considered low-LET (Linear Energy Transfer) radiation, have an average RBE (relative biological effectiveness) of 1.1, with a range from 0.7 to 1.6. Thus, increasing biological effectiveness is of high interest in radiation oncology, and one way to enhance this is by using radiosensitizers. The present work investigates the effectiveness of the proton boron fusion reaction (PBFR) at the cellular level, using the sodium salt of metallacarborane [3,3'-Co(C2B9H11)2]<sup>-</sup> (Na[o-COSAN]) as the boron source, aiming to explore the potential of this type of boron clusters as a radiosensitizer for proton therapy. Therefore, the main goal was to test the hypothesis that loading the cells with boron will favour the PBFR at energies close to the Bragg peak. This would enhance the radiation-induced biological effects through the production of alpha-particles.</p><p><strong>Results: </strong>MDA-MB-231 breast cancer cells were used. Nuclear microscopy assessed [o-COSAN] uptake and distribution in single cells, while biodistribution was studied in tumor-bearing Balb/cSlc-nu/nu mice (MDA-MB-231 xenograft), with boron accumulation in target organs and tumor measured by ICP-OES. The cells were irradiated with a proton beam tuned to reach the PBFR resonance energy of 675 keV at the cell layer. DNA damage was assessed with the g-H2AX assay and cell survival with the clonogenic assay. Beam parameters and dose calibration curves using radiochromic films validated Monte Carlo dosimetry simulations. As expected, we observed higher biological damage in irradiated cells and the presence of [o-COSAN]<sup>-</sup> potentiated the damage. These results translate into a lower cellular viability, indicating that DNA damage imposed colonies smaller than their non-irradiated counterparts. This suggests that these damages either took longer time to be repaired or made the cells undergo less efficient survival mechanisms.</p><p><strong>Conclusions: </strong>The radiosensitizing effect of [o-COSAN]<sup>-</sup> by strategic cellular <sup>11</sup>B placement and proton irradiation intensifies the DNA damage, making the nucleus particularly susceptible and thus increasing the destructive capability of alpha-particles, generated in the nuclear fusion reaction, which may lead to increased cell mortality.</p>","PeriodicalId":11611,"journal":{"name":"EJNMMI Research","volume":"15 1","pages":"13"},"PeriodicalIF":3.1000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11845649/pdf/","citationCount":"0","resultStr":"{\"title\":\"Unravelling physical and radiobiological effects of proton boron fusion reaction with anionic metallacarboranes ([o-COSAN]<sup>-</sup>) in breast cancer cells.\",\"authors\":\"Ana Belchior, Bianca C Alves, Edgar Mendes, Francisco Megre, Luís C Alves, Pedro Santos, Kai Nishimura, Hiroyuki Nakamura, Francesc Teixidor, Clara Viñas, Jorge Miguel Sampaio, Fernanda Marques, Teresa Pinheiro\",\"doi\":\"10.1186/s13550-025-01199-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Protons, which are considered low-LET (Linear Energy Transfer) radiation, have an average RBE (relative biological effectiveness) of 1.1, with a range from 0.7 to 1.6. Thus, increasing biological effectiveness is of high interest in radiation oncology, and one way to enhance this is by using radiosensitizers. The present work investigates the effectiveness of the proton boron fusion reaction (PBFR) at the cellular level, using the sodium salt of metallacarborane [3,3'-Co(C2B9H11)2]<sup>-</sup> (Na[o-COSAN]) as the boron source, aiming to explore the potential of this type of boron clusters as a radiosensitizer for proton therapy. Therefore, the main goal was to test the hypothesis that loading the cells with boron will favour the PBFR at energies close to the Bragg peak. This would enhance the radiation-induced biological effects through the production of alpha-particles.</p><p><strong>Results: </strong>MDA-MB-231 breast cancer cells were used. Nuclear microscopy assessed [o-COSAN] uptake and distribution in single cells, while biodistribution was studied in tumor-bearing Balb/cSlc-nu/nu mice (MDA-MB-231 xenograft), with boron accumulation in target organs and tumor measured by ICP-OES. The cells were irradiated with a proton beam tuned to reach the PBFR resonance energy of 675 keV at the cell layer. DNA damage was assessed with the g-H2AX assay and cell survival with the clonogenic assay. Beam parameters and dose calibration curves using radiochromic films validated Monte Carlo dosimetry simulations. As expected, we observed higher biological damage in irradiated cells and the presence of [o-COSAN]<sup>-</sup> potentiated the damage. These results translate into a lower cellular viability, indicating that DNA damage imposed colonies smaller than their non-irradiated counterparts. This suggests that these damages either took longer time to be repaired or made the cells undergo less efficient survival mechanisms.</p><p><strong>Conclusions: </strong>The radiosensitizing effect of [o-COSAN]<sup>-</sup> by strategic cellular <sup>11</sup>B placement and proton irradiation intensifies the DNA damage, making the nucleus particularly susceptible and thus increasing the destructive capability of alpha-particles, generated in the nuclear fusion reaction, which may lead to increased cell mortality.</p>\",\"PeriodicalId\":11611,\"journal\":{\"name\":\"EJNMMI Research\",\"volume\":\"15 1\",\"pages\":\"13\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-02-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11845649/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJNMMI Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13550-025-01199-6\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13550-025-01199-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
摘要
背景:质子被认为是低let(线性能量转移)辐射,其平均RBE(相对生物有效性)为1.1,范围为0.7至1.6。因此,提高生物有效性是放射肿瘤学的高度关注,提高这一点的一种方法是使用放射增敏剂。本研究利用金属碳硼烷钠盐[3,3'- co (C2B9H11)2]- (Na[o-COSAN])作为硼源,在细胞水平上研究质子硼融合反应(PBFR)的有效性,旨在探索这类硼簇作为质子治疗放射增敏剂的潜力。因此,主要目标是验证这样一个假设,即在细胞中装载硼将有利于接近布拉格峰能量的PBFR。这将通过产生α粒子来增强辐射诱导的生物效应。结果:采用MDA-MB-231乳腺癌细胞。核显微镜评估了[o-COSAN]在单个细胞中的摄取和分布,同时研究了荷瘤Balb/cSlc-nu/nu小鼠(MDA-MB-231异种移植物)的生物分布,并通过ICP-OES测量了靶器官和肿瘤中的硼积累。用质子束照射细胞,使其在细胞层达到675 keV的PBFR共振能量。用g-H2AX法评估DNA损伤,用克隆性法评估细胞存活。使用放射致色膜的光束参数和剂量校准曲线验证了蒙特卡罗剂量学模拟。正如预期的那样,我们在辐照细胞中观察到更高的生物损伤,而[o-COSAN]-的存在加剧了这种损伤。这些结果转化为较低的细胞活力,表明DNA损伤施加的菌落比未辐照的同类更小。这表明,这些损伤要么需要更长的时间来修复,要么使细胞经历更低效的生存机制。结论:策略性放置细胞11B和质子照射[o-COSAN]-的放射增敏作用加剧了DNA损伤,使细胞核特别敏感,从而增加了核聚变反应中产生的α粒子的破坏能力,可能导致细胞死亡率增加。
Unravelling physical and radiobiological effects of proton boron fusion reaction with anionic metallacarboranes ([o-COSAN]-) in breast cancer cells.
Background: Protons, which are considered low-LET (Linear Energy Transfer) radiation, have an average RBE (relative biological effectiveness) of 1.1, with a range from 0.7 to 1.6. Thus, increasing biological effectiveness is of high interest in radiation oncology, and one way to enhance this is by using radiosensitizers. The present work investigates the effectiveness of the proton boron fusion reaction (PBFR) at the cellular level, using the sodium salt of metallacarborane [3,3'-Co(C2B9H11)2]- (Na[o-COSAN]) as the boron source, aiming to explore the potential of this type of boron clusters as a radiosensitizer for proton therapy. Therefore, the main goal was to test the hypothesis that loading the cells with boron will favour the PBFR at energies close to the Bragg peak. This would enhance the radiation-induced biological effects through the production of alpha-particles.
Results: MDA-MB-231 breast cancer cells were used. Nuclear microscopy assessed [o-COSAN] uptake and distribution in single cells, while biodistribution was studied in tumor-bearing Balb/cSlc-nu/nu mice (MDA-MB-231 xenograft), with boron accumulation in target organs and tumor measured by ICP-OES. The cells were irradiated with a proton beam tuned to reach the PBFR resonance energy of 675 keV at the cell layer. DNA damage was assessed with the g-H2AX assay and cell survival with the clonogenic assay. Beam parameters and dose calibration curves using radiochromic films validated Monte Carlo dosimetry simulations. As expected, we observed higher biological damage in irradiated cells and the presence of [o-COSAN]- potentiated the damage. These results translate into a lower cellular viability, indicating that DNA damage imposed colonies smaller than their non-irradiated counterparts. This suggests that these damages either took longer time to be repaired or made the cells undergo less efficient survival mechanisms.
Conclusions: The radiosensitizing effect of [o-COSAN]- by strategic cellular 11B placement and proton irradiation intensifies the DNA damage, making the nucleus particularly susceptible and thus increasing the destructive capability of alpha-particles, generated in the nuclear fusion reaction, which may lead to increased cell mortality.
EJNMMI ResearchRADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb-
CiteScore
5.90
自引率
3.10%
发文量
72
审稿时长
13 weeks
期刊介绍:
EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.
The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.